BioCentury
ARTICLE | Clinical News

MNK-155: Phase III data

December 16, 2013 8:00 AM UTC

A double-blind, U.S. Phase III trial in about 400 patients with moderate to severe acute pain following a unilateral first metatarsal bunionectomy showed that a loading dose of 3 tablets of oral MNK-1...